Dengue, New England Journal of Medicine, vol.366, issue.15, pp.1423-1432, 2012. ,
DOI : 10.1056/NEJMra1110265
URL : https://hal.archives-ouvertes.fr/pasteur-01176423
Dengue?quotuetquovadis?Viruses, pp.1562-1608, 2011. ,
Research on dengue during World War II, Am J Trop Med Hyg, vol.1, pp.30-50, 1952. ,
RISK FACTORS IN DENGUE SHOCK SYNDROME: A PROSPECTIVE EPIDEMIOLOGIC STUDY IN RAYONG, THAILAND, American Journal of Epidemiology, vol.120, issue.5, pp.653-669, 1984. ,
DOI : 10.1093/oxfordjournals.aje.a113932
Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes, The Lancet Infectious Diseases, vol.10, issue.10, pp.712-722, 2010. ,
DOI : 10.1016/S1473-3099(10)70166-3
An In-Depth Analysis of Original Antigenic Sin in Dengue Virus Infection, Journal of Virology, vol.85, issue.1, pp.410-421, 2011. ,
DOI : 10.1128/JVI.01826-10
Analysis of specific IgM responses in secondary dengue virus infections: levels and positive rates in comparison with primary infections, Journal of Clinical Virology, vol.31, issue.3, pp.185-189, 2004. ,
DOI : 10.1016/j.jcv.2004.03.005
Specific IgM and IgG responses in primary and secondary dengue virus infections determined by enzyme-linked immunosorbent assay, Epidemiology and Infection, vol.134, issue.04, pp.820-825, 2006. ,
DOI : 10.1017/S0950268805005753
Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody, Journal of Experimental Medicine, vol.146, issue.1, pp.201-217, 1977. ,
DOI : 10.1084/jem.146.1.201
Analysis of functional epitopes on the dengue 2 envelope (E) protein using monoclonal IgM antibodies, Archives of Virology, vol.84, issue.5, pp.899-913, 1995. ,
DOI : 10.1007/BF01314966
Anamnestic antibody response after viral challenge in monkeys immunized with dengue 2 recombinant fusion proteins, Archives of Virology, vol.308, issue.5, pp.849-854, 2008. ,
DOI : 10.1007/s00705-008-0050-9
Functional analysis of human memory B-cell subpopulations: IgD+CD27+ B cells are crucial in secondary immune response by producing high affinity IgM, Clinical Immunology, vol.108, issue.2, pp.128-137, 2003. ,
DOI : 10.1016/S1521-6616(03)00092-5
Induction of protective immunity against Dengue virus type 2: comparison of candidate live attenuated and recombinant vaccines, Vaccine, vol.17, issue.11-12, pp.1312-1320, 1999. ,
DOI : 10.1016/S0264-410X(98)00393-4
Laboratory diagnosis of dengue virus infections In Dengue and Dengue Hemorrhagic Fever, Cambridge: CAB International, pp.313-333, 1997. ,
Serotype-crossreactive immunoglobulin M responses in dengue virus infections determined by enzyme-linked immunosorbent assay, Clin Diagn Lab Immunol, vol.7, pp.774-777, 2000. ,
Dengue Virus Serotyping Based on Envelope and Membrane and Nonstructural Protein NS1 Serotype-Specific Capture Immunoglobulin M Enzyme-Linked Immunosorbent Assays, Journal of Clinical Microbiology, vol.42, issue.6, pp.2489-2494, 2004. ,
DOI : 10.1128/JCM.42.6.2489-2494.2004
Comparative Analysis of Immunoglobulin M (IgM) Capture Enzyme-Linked Immunosorbent Assay Using Virus-Like Particles or Virus-Infected Mouse Brain Antigens To Detect IgM Antibody in Sera from Patients with Evident Flaviviral Infections, Journal of Clinical Microbiology, vol.43, issue.7, pp.3227-3236, 2005. ,
DOI : 10.1128/JCM.43.7.3227-3236.2005
Dengue and dengue hemorrhagic fever, Clin Microbiol Rev, vol.11, pp.480-496, 1998. ,
Structure of Dengue Virus: Implications for Flavivirus Organization, Maturation, and Fusion, Cell, vol.108, pp.717-725, 2002. ,
DOI : 10.1142/9789814513357_0037
A ligand-binding pocket in the dengue virus envelope glycoprotein, Proceedings of the National Academy of Sciences, vol.100, issue.12, pp.6986-6991, 2003. ,
DOI : 10.1073/pnas.0832193100
Conformational Changes of the Flavivirus E Glycoprotein, Structure, vol.12, issue.9, pp.1607-1618, 2004. ,
DOI : 10.1016/j.str.2004.06.019
Variable Surface Epitopes in the Crystal Structure of Dengue Virus Type 3 Envelope Glycoprotein, Journal of Virology, vol.79, issue.2 ,
DOI : 10.1128/JVI.79.2.1223-1231.2005
Structural insights into the neutralization mechanism of a higher primate antibody against dengue virus, The EMBO Journal, vol.12, issue.3, pp.767-779, 2012. ,
DOI : 10.1038/emboj.2011.439
Solution structure of the envelope protein domain III of dengue-4 virus, Virology, vol.364, issue.1, pp.147-154, 2007. ,
DOI : 10.1016/j.virol.2007.02.023
Solution structure and neutralizing antibody binding studies of domain III of the dengue-2 virus envelope protein, Proteins: Structure, Function, and Bioinformatics, vol.176, issue.3, pp.1116-1119, 2008. ,
DOI : 10.1002/prot.21806
Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins, Nature Structural & Molecular Biology, vol.148, issue.3, pp.312-317, 2008. ,
DOI : 10.1038/nsmb.1382
Rapid Structural Characterization of Human Antibody???Antigen Complexes through Experimentally Validated Computational Docking, Journal of Molecular Biology, vol.396, issue.5, pp.1491-1507, 2010. ,
DOI : 10.1016/j.jmb.2009.12.053
Mechanism of Dengue Virus Broad Cross-Neutralization by a Monoclonal Antibody, Structure, vol.20, issue.2, pp.303-314, 2012. ,
DOI : 10.1016/j.str.2012.01.001
Structural Analysis of a Dengue Cross-Reactive Antibody Complexed with Envelope Domain III Reveals the Molecular Basis of Cross-Reactivity, The Journal of Immunology, vol.188, issue.10, pp.4971-4979, 2012. ,
DOI : 10.4049/jimmunol.1200227
High resolution crystal structure of dengue-3 envelope protein domain III suggests possible molecular mechanisms for serospecific antibody recognition, Proteins: Structure, Function, and Bioinformatics, vol.100, issue.6, pp.1090-1095, 2013. ,
DOI : 10.1002/prot.24237
Structural Basis of Differential Neutralization of DENV-1 Genotypes by an Antibody that Recognizes a Cryptic Epitope, PLoS Pathogens, vol.8, issue.10, p.1002930, 2012. ,
DOI : 10.1371/journal.ppat.1002930.s007
Rational Engineering of a Human Anti-Dengue Antibody through Experimentally Validated Computational Docking, PLoS ONE, vol.37, issue.2, p.55561, 2013. ,
DOI : 10.1371/journal.pone.0055561.s006
Demonstration of binding of dengue virus envelope protein to target cells, J Virol, vol.70, pp.8765-8772, 1996. ,
Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: insight into the neutralization mechanism, Journal of General Virology, vol.82, issue.8, pp.1885-1892, 2001. ,
DOI : 10.1099/0022-1317-82-8-1885
An External Loop Region of Domain III of Dengue Virus Type 2 Envelope Protein Is Involved in Serotype-Specific Binding to Mosquito but Not Mammalian Cells, Journal of Virology, vol.78, issue.1 ,
DOI : 10.1128/JVI.78.1.378-388.2004
Bacterially expressed and refolded envelope protein (domain III) of dengue virus type-4 binds heparan sulfate, Journal of Chromatography B, vol.846, issue.1-2, pp.184-194, 2007. ,
DOI : 10.1016/j.jchromb.2006.08.051
Characterization of the interaction of domain III of the envelope protein of dengue virus with putative receptors from CHO cells, Virus Research, vol.137, issue.2, pp.225-234, 2008. ,
DOI : 10.1016/j.virusres.2008.07.022
Molecular mechanisms involved in the early steps of flavivirus cell entry, Microbes and Infection, vol.13, issue.1, pp.1-9, 2011. ,
DOI : 10.1016/j.micinf.2010.09.005
Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan binding, Journal of General Virology, vol.93, issue.1, pp.72-82, 2012. ,
DOI : 10.1099/vir.0.037317-0
The folded and disordered domains of human ribosomal protein SA have both idiosyncratic and shared functions as membrane receptors, Bioscience Reports, vol.66, issue.1, p.11, 2013. ,
DOI : 10.1038/nsmb1228
High-level expression and one-step purification of recombinant dengue virus type 2 envelope domain III protein in Escherichia coli, Protein Expression and Purification, vol.33, issue.1, pp.80-91, 2004. ,
DOI : 10.1016/j.pep.2003.09.009
The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry, Microbes and Infection, vol.9, issue.1, pp.1-6, 2007. ,
DOI : 10.1016/j.micinf.2006.09.009
Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization, Biologicals, vol.38, issue.6, pp.613-618, 2010. ,
DOI : 10.1016/j.biologicals.2010.07.004
Replication of dengue virus type 2 in human monocyte-derived macrophages: comparisons of isolates and recombinant viruses with substitutions at amino acid 390 in the envelope glycoprotein, Am J Trop Med Hyg, vol.65, pp.427-434, 2001. ,
Amino acid and phenotypic changes in dengue 2 virus associated with escape from neutralisation by IgM antibody, Journal of Medical Virology, vol.93, issue.2 ,
DOI : 10.1002/jmv.2036
Humoral Immune Responses of Dengue Fever Patients Using Epitope-Specific Serotype-2 Virus-Like Particle Antigens, PLoS ONE, vol.10, issue.1, pp.1471-2334302, 2009. ,
DOI : 10.1371/journal.pone.0004991.t008
Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody, Virology, vol.392, issue.1, pp.103-113, 2009. ,
DOI : 10.1016/j.virol.2009.06.037
Evaluation of recombinant dengue viral envelope B domain protein antigens for the detection of dengue complex-specific antibodies ,
Use of Recombinant E Protein Domain III-Based Enzyme-Linked Immunosorbent Assays for Differentiation of Tick-Borne Encephalitis Serocomplex Flaviviruses from Mosquito-Borne Flaviviruses, Journal of Clinical Microbiology, vol.42, issue.9, pp.4101-4110, 2004. ,
DOI : 10.1128/JCM.42.9.4101-4110.2004
Evaluation of envelope domain III-based single chimeric tetravalent antigen and monovalent antigen mixtures for the detection of anti-dengue antibodies in human sera, BMC Infectious Diseases, vol.392, issue.1, p.64, 2011. ,
DOI : 10.1016/j.virol.2009.06.037
Evaluation of the protective efficacy of a recombinant dengue envelope B domain fusion protein against dengue 2 virus infection in mice, Am J Trop Med Hyg, vol.58, pp.655-662, 1998. ,
High-level expression of recombinant dengue virus type 2 envelope domain III protein and induction of neutralizing antibodies in BALB/C mice, Journal of Virological Methods, vol.143, issue.2 ,
DOI : 10.1016/j.jviromet.2007.02.012
Immunogenicity of a recombinant envelope domain III protein of dengue virus type-4 with various adjuvants in mice, Vaccine, vol.26, issue.36, pp.4655-4663, 2008. ,
DOI : 10.1016/j.vaccine.2008.07.006
Pichia pastoris-expressed dengue virus type 2 envelope domain III elicits virus-neutralizing antibodies, Journal of Virological Methods, vol.167, issue.1, pp.10-16, 2010. ,
DOI : 10.1016/j.jviromet.2010.03.002
Domain III of the envelope protein as a dengue vaccine target, Expert Review of Vaccines, vol.9, issue.2, pp.137-147, 2010. ,
DOI : 10.1586/erv.09.139
Induction of neutralizing antibodies specific to dengue virus serotypes 2 and 4 by a bivalent antigen composed of linked envelope domains III of these two serotypes, Am J Trop Med Hyg, vol.74, pp.266-277, 2006. ,
Induction of Tetravalent Protective Immunity Against Four Dengue Serotypes by the Tandem Domain III of the Envelope Protein, DNA and Cell Biology, vol.26, issue.6, pp.361-367, 2007. ,
DOI : 10.1089/dna.2006.0547
An envelope domain III-based chimeric antigen produced in pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes, Am J Trop Med Hyg, vol.79, pp.353-363, 2008. ,
Pediatric Measles Vaccine Expressing a Dengue Antigen Induces Durable Serotype-specific Neutralizing Antibodies to Dengue Virus, PLoS Neglected Tropical Diseases, vol.61, issue.3, p.96, 2007. ,
DOI : 10.1371/journal.pntd.0000096.s002
URL : https://hal.archives-ouvertes.fr/pasteur-00285763
An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity, Vaccine, vol.27, issue.43, pp.6011-6021, 2009. ,
DOI : 10.1016/j.vaccine.2009.07.073
Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses, Vaccine, vol.28, issue.41, pp.6730-6739, 2010. ,
DOI : 10.1016/j.vaccine.2010.07.073
URL : https://hal.archives-ouvertes.fr/pasteur-00530065
PCP Consensus Sequences of Flaviviruses: Correlating Variance with Vector Competence and Disease Phenotype, Journal of Molecular Biology, vol.396, issue.3 ,
DOI : 10.1016/j.jmb.2009.11.070
Simplifying complex sequence information: A PCP-consensus protein binds antibodies against all four Dengue serotypes, Vaccine, vol.30, issue.42, pp.6081-6087, 2012. ,
DOI : 10.1016/j.vaccine.2012.07.042
Clinical and Virological Study of Dengue Cases and the Members of Their Households: The Multinational DENFRAME Project, PLoS Neglected Tropical Diseases, vol.82, issue.1, p.1482, 2012. ,
DOI : 10.1371/journal.pntd.0001482.s004
URL : https://hal.archives-ouvertes.fr/pasteur-00667837
Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications. European Patent Office, p.2003144, 2008. ,
Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine, Clin Chem, vol.39, pp.561-577, 1993. ,
The meaning and use of the area under a receiver operating characteristic (ROC) curve., Radiology, vol.143, issue.1, pp.29-36, 1982. ,
DOI : 10.1148/radiology.143.1.7063747
Maximum likelihood estimation of receiver operating characteristic (ROC) curves from continuously-distributed data, pp.1033-1053, 1998. ,
ROC analysis: web-based calculator for ROC curves ,
Thermodynamic stability of domain III from the envelope protein of flaviviruses and its improvement by molecular design, Protein Engineering Design and Selection, vol.26, issue.6, pp.389-399, 2013. ,
DOI : 10.1093/protein/gzt010
Mapping to completeness and transplantation of a group-specific, discontinuous, neutralizing epitope in the envelope protein of dengue virus, Journal of General Virology, vol.88, issue.9, pp.2387-2397, 2007. ,
DOI : 10.1099/vir.0.83028-0
URL : https://hal.archives-ouvertes.fr/pasteur-00175708
NKp44 Receptor Mediates Interaction of the Envelope Glycoproteins from the West Nile and Dengue Viruses with NK Cells, The Journal of Immunology, vol.183, issue.4, pp.2610-2621, 2009. ,
DOI : 10.4049/jimmunol.0802806
URL : https://hal.archives-ouvertes.fr/pasteur-00588928
Visualization of membrane protein domains by cryo-electron microscopy of dengue virus, Nature Structural Biology, vol.10, issue.11, pp.907-912, 2003. ,
DOI : 10.1038/nsb990
The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity, Cell Host & Microbe, vol.8, issue.3, pp.271-283, 2010. ,
DOI : 10.1016/j.chom.2010.08.007
URL : https://hal.archives-ouvertes.fr/pasteur-00530282
Characterization of Dengue Virus Complex-Specific Neutralizing Epitopes on Envelope Protein Domain III of Dengue 2 Virus, Journal of Virology, vol.82, issue.17, pp.8828-8837, 2008. ,
DOI : 10.1128/JVI.00606-08
Sun W: Phase I trial of 16 formulations of a tetravalent live ,
Dengue tetravalent DNA vaccine inducing neutralizing antibody and anamnestic responses to four serotypes in mice, Vaccine, vol.24, issue.12, pp.2200-2207, 2006. ,
DOI : 10.1016/j.vaccine.2005.11.002